QuantiFERON Change During Anti-tuberculosis Medication

Armed Forces Capital Hospital, Republic of Korea50 enrolled

Overview

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Tuberculosis Interferon-gamma Release Assay

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All subjects with active tuberculosis Exclusion Criteria: * Subjects who cannot complete study * Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital

Locations (1)

Armed Forces Capital Hospital

Seongnam-si, Gyeonggi-do, South Korea

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.